PHA Classroom banner

>> Back to Recordings
Session Recording from 2011
PHA on the Road, Minneapolis

What Is on the Horizon for PAH? (Clinical Trials)

June 18, 2011

Clinical trials in PAH have led to FDA approval of nine therapies over the past 13 years! This presentation will highlight the various clinical trials that are currently active and briefly discuss the trials that have recently been completed.

View the recording (recording will open in a new window)

Presenter Information

Michael D. McGoon, MD, Mayo Clinic, Rochester, Minn.

>>If you liked this recording, you may enjoy PIM-1: A New Hope for the Diagnosis and Treatment of PH

PIM-1: A New Hope for the Diagnosis and Treatment of PH





Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. Bayer HealthCare United Therapeutics Corporation
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.


FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2015 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.